Ethic Inc. Has $472,000 Stock Holdings in Dolby Laboratories $DLB

Ethic Inc. cut its stake in shares of Dolby Laboratories (NYSE:DLB) by 4.0% in the 2nd quarter, according to its most recent Form 13F filing with the SEC. The fund owned 6,378 shares of the electronics maker’s stock after selling 266 shares during the period. Ethic Inc.’s holdings in Dolby Laboratories were worth $472,000 as of its most recent filing with the SEC.

Other hedge funds also recently made changes to their positions in the company. Bayforest Capital Ltd bought a new position in shares of Dolby Laboratories during the second quarter worth approximately $147,000. Equitable Trust Co. boosted its holdings in shares of Dolby Laboratories by 3.3% in the 2nd quarter. Equitable Trust Co. now owns 5,567 shares of the electronics maker’s stock valued at $413,000 after purchasing an additional 177 shares in the last quarter. Boston Trust Walden Corp boosted its holdings in shares of Dolby Laboratories by 2.1% in the 2nd quarter. Boston Trust Walden Corp now owns 1,098,218 shares of the electronics maker’s stock valued at $81,554,000 after purchasing an additional 22,404 shares in the last quarter. TD Asset Management Inc boosted its holdings in shares of Dolby Laboratories by 41.5% during the 2nd quarter. TD Asset Management Inc now owns 16,700 shares of the electronics maker’s stock valued at $1,240,000 after acquiring an additional 4,900 shares in the last quarter. Finally, Sequoia Financial Advisors LLC acquired a new stake in shares of Dolby Laboratories during the 2nd quarter valued at $550,000. 58.56% of the stock is owned by institutional investors and hedge funds.

Dolby Laboratories Stock Performance

Dolby Laboratories stock opened at $66.64 on Wednesday. The stock has a market cap of $6.39 billion, a P/E ratio of 24.41 and a beta of 0.92. Dolby Laboratories has a fifty-two week low of $66.52 and a fifty-two week high of $89.66. The firm’s fifty day moving average price is $71.13 and its 200-day moving average price is $73.43.

Dolby Laboratories (NYSE:DLB) last released its quarterly earnings results on Thursday, July 31st. The electronics maker reported $0.78 earnings per share for the quarter, topping the consensus estimate of $0.72 by $0.06. The firm had revenue of $315.55 million for the quarter, compared to analysts’ expectations of $305.23 million. Dolby Laboratories had a net margin of 19.62% and a return on equity of 11.52%. The business’s quarterly revenue was up 9.2% on a year-over-year basis. During the same quarter in the prior year, the firm posted $0.71 earnings per share. Dolby Laboratories has set its FY 2025 guidance at 3.880-4.030 EPS. Q4 2025 guidance at 0.610-0.760 EPS. Sell-side analysts predict that Dolby Laboratories will post 2.94 earnings per share for the current year.

Dolby Laboratories Announces Dividend

The company also recently announced a quarterly dividend, which was paid on Wednesday, August 20th. Stockholders of record on Tuesday, August 12th were issued a dividend of $0.33 per share. This represents a $1.32 dividend on an annualized basis and a dividend yield of 2.0%. The ex-dividend date was Tuesday, August 12th. Dolby Laboratories’s dividend payout ratio is currently 48.35%.

Insider Transactions at Dolby Laboratories

In other news, CEO Kevin J. Yeaman sold 25,000 shares of the stock in a transaction dated Tuesday, October 14th. The shares were sold at an average price of $68.87, for a total transaction of $1,721,750.00. Following the completion of the sale, the chief executive officer directly owned 114,725 shares in the company, valued at approximately $7,901,110.75. This represents a 17.89% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is accessible through this hyperlink. Also, SVP Shriram Revankar sold 7,000 shares of the firm’s stock in a transaction dated Friday, August 22nd. The stock was sold at an average price of $74.92, for a total transaction of $524,440.00. Following the completion of the sale, the senior vice president owned 70,435 shares of the company’s stock, valued at $5,276,990.20. This trade represents a 9.04% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. Over the last quarter, insiders have sold 82,000 shares of company stock valued at $5,845,440. 38.39% of the stock is currently owned by company insiders.

Wall Street Analyst Weigh In

Several research analysts have commented on DLB shares. Baird R W raised Dolby Laboratories to a “hold” rating in a report on Friday, September 5th. Weiss Ratings reissued a “hold (c)” rating on shares of Dolby Laboratories in a research report on Wednesday, October 8th. Barrington Research reaffirmed an “outperform” rating and issued a $100.00 target price on shares of Dolby Laboratories in a research report on Friday, September 12th. Rosenblatt Securities reissued a “buy” rating and set a $95.00 price objective on shares of Dolby Laboratories in a report on Friday, August 1st. Finally, Wall Street Zen raised Dolby Laboratories from a “hold” rating to a “buy” rating in a report on Saturday, August 30th. Three research analysts have rated the stock with a Buy rating and three have issued a Hold rating to the company. According to data from MarketBeat.com, the stock presently has a consensus rating of “Moderate Buy” and an average target price of $95.75.

About Dolby Laboratories

Dolby Laboratories, Inc creates audio and imaging technologies that transform entertainment at the cinema, DTV transmissions and devices, mobile devices, OTT video and music services, home entertainment devices, and automobiles. The company develops and licenses its audio technologies, such as AAC & HE-AAC, a digital audio codec solution used for a range of media applications; AVC, a digital video codec with high bandwidth efficiency used in various media devices; Dolby AC-4, a digital audio coding technology that delivers new audio experiences to a range of playback devices; and Dolby Atmos technology for cinema and various media devices.